Federal contractor profile
DIXON-SHANE, LLC
UEI EY4NEQ739DJ7CAGE 5J522
Overview
- Legal name
- DIXON-SHANE, LLC
- Latest award activity
- Oct 6, 2025
Read company summary
DIXON-SHANE, LLC is associated with UEI EY4NEQ739DJ7 and CAGE 5J522 in public federal records. AcornBids currently links 24 prime awards totaling $44.9K in obligations to this entity. Its largest recorded federal customer by obligations is Department of Defense. Its recorded federal awards include work classified as Pharmaceutical Preparation Manufacturing; Medicinal and Botanical Manufacturing. These categories describe the loaded award records, not a complete list of company capabilities.
At a glance
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Oct 13, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- DIXON-SHANE, LLC
- UEI
- EY4NEQ739DJ7
- CAGE
- 5J522
- Registration status
- SAM registration status unavailable
Research brief
Source facts
- Loaded prime-award records link 24 awards and $44,882 in reported obligations to this legal entity. Source
- Recorded awards include Pharmaceutical Preparation Manufacturing (NAICS 325412); this classification is not proof of every company capability. Source
- An example award describes: 8505429839!TETANUS TOXOID,REDU Source
Federal award analysis
Net transaction obligations by federal fiscal period.
Reported transaction obligations by federal fiscal period; includes deobligations. Missing transactions are not estimated. Coverage: 24 of 24 selected awards. Select a period to explore its awards.
Funding change
Dated, valued transaction obligations in equal-length adjacent periods; missing records are unknown. Default: last completed federal fiscal year. Percentage is unavailable when the prior period has no positive reported obligations.
| Measure | Reported value |
|---|---|
| Current period | Oct 1, 2025 – Sep 30, 2026 |
| Current obligations | $-844 |
| Prior period | Oct 1, 2024 – Sep 30, 2025 |
| Prior obligations | $-4.6K |
| Change | $3.8K |
| Growth | Not comparable |
Where the work is performed
State tile map; darker tiles have larger absolute net obligations. Outlined tiles indicate net deobligations. Unshaded tiles have no reported transactions in this selection. Other locations appear in the table.
Agencies
| Category | Period obligations | Awards |
|---|---|---|
| Department of Defense | $39.4K | 24 |
Offices
| Category | Period obligations | Awards |
|---|---|---|
| DLA TROOP SUPPORT | $39.4K | 24 |
Naics
| Category | Period obligations | Awards |
|---|---|---|
| 325412 — Pharmaceutical Preparation Manufacturing | $44.9K | 1 |
| 325411 — Medicinal and Botanical Manufacturing | $-5.4K | 23 |
Psc
| Category | Period obligations | Awards |
|---|---|---|
| 6505 — Drugs and Biologicals | $39.4K | 24 |
Vehicles
| Category | Period obligations | Awards |
|---|---|---|
| SPE2D019D5003 | $44.9K | 1 |
| SPM2D008D0252 | $-5.4K | 23 |
States
| Category | Period obligations | Awards |
|---|---|---|
| PA | $39.4K | 24 |
Set Asides
| Category | Period obligations | Awards |
|---|---|---|
| Unclassified | $39.4K | 24 |
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| SPE2D018F01168505429839!TETANUS TOXOID,REDU | Department of Defense | $0 | Apr 24, 2018 | May 24, 2018 |
| SPE2D018F01178505429970!HEPATITIS B VIRUS V | Department of Defense | $0 | Apr 24, 2018 | May 24, 2018 |
| SPE2D020F01248507033708!OTHER MEDICAL | Department of Defense | $44.9K | Dec 11, 2019 | Dec 11, 2019 |
| SPE2D018F00658505201884!ESTRADIOL VAG CR,US | Department of Defense | $0 | Feb 14, 2018 | Mar 16, 2018 |
| SPE2D018F00688505225878!NAPROXEN TABLETS,US | Department of Defense | $0 | Feb 22, 2018 | Mar 26, 2018 |
| SPE2D018F00798505274336!ESTRADIOL VAG CR,US | Department of Defense | $0 | Mar 7, 2018 | Apr 6, 2018 |
| SPE2D018F00818505274730!ESTRADIOL VAG CR,US | Department of Defense | $0 | Mar 7, 2018 | Apr 6, 2018 |
| SPE2D018F00828505274734!ESTRADIOL VAG CR,US | Department of Defense | $0 | Mar 7, 2018 | Apr 6, 2018 |
| SPE2D018F00838505274687!ESTRADIOL VAG CR,US | Department of Defense | $0 | Mar 7, 2018 | Apr 6, 2018 |
| SPE2D018F00858505283008!OMEPRAZOLE EXTENDED | Department of Defense | $0 | Mar 9, 2018 | Apr 9, 2018 |
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Not available |
| Source loaded | Sep 26, 2026 |
| Initial registration | Not available |
| Entity start | Not available |
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
Disclosed relationships only. Missing records do not establish that a contractor has no partners. Ambiguous parent award identifiers are excluded.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit